HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies.

AbstractOBJECTIVE AND METHOD:
The fluorometric microculture cytotoxic assay was employed for characterisation of the cytotoxic effect of cyclosporin A (CsA) and its non-immunosuppressive analogue SDZ PSC 833, [3-keto-Bmt1]-[Val2]-cyclosporin (PSC) in tumour cells from patients with haematological or solid tumours.
RESULTS:
Tumour cells from patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma (NHL) were found to be more sensitive to both drugs than those of tumour cells from patients with acute lymphocytic leukemia (ALL), acute myoblastic leukaemia (AML) and various solid tumours. There was a close correlation between the effects of the two drugs (correlation coefficient 0.71), but CsA was slightly more active than PSC in most diagnoses. No tumour cells sample showed sensitivity to PSC without also being sensitive to CsA. There was a moderate level of correlation between the activity pattern of CsA and doxorubicin (correlation coefficient 0.66), whereas the correlations with other cytostatics, such as vincristine, cytarabine and melphalan, were low (correlation coefficient -0.11 to 0.33).
CONCLUSION:
The results indicate that PSC shares the direct cytotoxic properties of CsA, but is slightly less potent. Clinical testing of the cytotoxic effect of these agents in haematological malignancies seems warranted and the apparent non-cross-resistance with standard agents makes cyclosporins a potentially useful adjunct to chemotherapy in those diagnoses.
AuthorsP Martinsson, P Nygren, H Fridborg, K Nilsson, J Kristensen, R Larsson
JournalEuropean journal of clinical pharmacology (Eur J Clin Pharmacol) Vol. 52 Issue 3 Pg. 199-203 ( 1997) ISSN: 0031-6970 [Print] Germany
PMID9218926 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Cyclosporins
  • Cyclosporine
  • valspodar
Topics
  • Antineoplastic Agents (pharmacology)
  • Cell Survival (drug effects)
  • Cyclosporine (pharmacology)
  • Cyclosporins (pharmacology)
  • Drug Screening Assays, Antitumor
  • Hematologic Neoplasms (drug therapy)
  • Humans
  • Tumor Cells, Cultured (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: